Axogen, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
AXGN Nasdaq 3840 www.axogeninc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Axogen, Inc.

Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - Feb 10th, 2026 5:00 am
Breakeven Is Near for Axogen, Inc. (NASDAQ:AXGN) - Feb 10th, 2026 3:42 am
A Look At Axogen (AXGN) Valuation After Its Upsized US$124 Million Equity Offering - Jan 24th, 2026 1:10 pm
Axogen (AXGN) Is Up 5.8% After Upsized Equity Raise and Debt Paydown - What's Changed - Jan 23rd, 2026 10:08 pm
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Ahead of Economic Data Releases - Jan 22nd, 2026 6:24 am
Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock - Jan 21st, 2026 9:18 pm
Axogen Announces Proposed Public Offering of Common Stock - Jan 21st, 2026 2:09 pm
AxoGen Touts Post-BLA Growth Plan, 75%+ Gross Margin Outlook at J.P. Morgan Healthcare Conference - Jan 15th, 2026 1:07 pm
Axogen CEO Axed 25,000 Shares From His Direct Holdings - Jan 14th, 2026 5:27 am
Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025 - Jan 12th, 2026 5:00 am
Should You Think About Buying Axogen, Inc. (NASDAQ:AXGN) Now? - Jan 7th, 2026 9:21 am
Are Investors Undervaluing Axogen, Inc. (NASDAQ:AXGN) By 31%? - Dec 22nd, 2025 4:04 am
Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference - Dec 17th, 2025 5:00 am
Three Stocks Estimated To Be Trading Below Intrinsic Value In December 2025 - Dec 5th, 2025 10:38 am
Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx) - Dec 3rd, 2025 6:01 pm
Axogen (NASDAQ:AXGN) shareholder returns have been strong, earning 161% in 3 years - Nov 27th, 2025 5:41 am
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences - Nov 4th, 2025 5:00 am
3 Stocks Estimated To Be Trading Below Their Fair Value In October 2025 - Oct 31st, 2025 5:38 am
Axogen (AXGN): Revenue Forecast to Grow 13.8% Annually Heading Into Earnings Season - Oct 30th, 2025 4:13 pm
AxoGen (AXGN) Q3 Earnings and Revenues Top Estimates - Oct 29th, 2025 6:15 am